Middle East & Africa dPCR and qPCR Market Forecast to 2030 - Regional Analysis - By Treatment, Product, Application, and End User

Description

List of Tables

The Middle East & Africa dPCR and qPCR market was valued at US$ 359.30 million in 2022 and is expected to reach US$ 504.97 million by 2030; it is estimated to grow at a CAGR of 4.3% from 2022 to 2030.

Development of Droplet Digital PCR Drives Middle East & Africa dPCR and qPCR Market

Droplet Digital PCR (ddPCR) is a new technique for performing digital PCR. It utilizes water-oil emulsion droplet technology. A sample to be tested is fractionated into around 20,000 droplets, and then amplification of the target DNA strand is carried out in each droplet. The ddPCR then digitally measures the nucleic acid targets in the individual droplet. Thus, the technique gives high precision and absolute quantification of target DNA molecules and enables wide application in diagnosis and research. In qPCR, DNA quantification is obtained from the cycle threshold (CT). External calibrators are required, and imperfect amplification affects absolute quantitation. Droplet Digital PCR (ddPCR) directly counts the target DNA without the calibration curve. Thus, with the advent of ddPCR, scientists will be able to explore complex genetic landscapes, discover and validate new disease associations, and define a new era of molecular diagnostics. Thus, development of ddPCR would become a major trend in the Middle East & Africa dPCR and qPCR market in the future.

Middle East & Africa dPCR and qPCR Market Overview

The Middle East & Africa dPCR and qPCR market in the Middle East & Africa is segmented into UAE, Saudi Arabia, South Africa, and the Rest of the Middle East & Africa. The region is expected to experience a significant growth due to increase in developments of varied reagent systems and automated systems in this region, introduction of a wide range of new products in diagnostic laboratories, and growing number of conferences, meetings, workshops and symposiums is expected to grow the molecular diagnostics awareness market in Middles East & Africa region.

Middle East & Africa dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Million)

Middle East & Africa dPCR and qPCR Market Segmentation

The Middle East & Africa dPCR and qPCR market is segmented based on treatment, product, application, end user, and country.

Based on treatment, the Middle East & Africa dPCR and qPCR market is bifurcated into quantitative PCR (qPCR) and digital PCR (dPCR). The digital PCR (dPCR) segment held a larger share in 2022.

By product, the Middle East & Africa dPCR and qPCR market is segmented into reagents & consumables, instruments, and software & services. The reagents & consumables segment held the largest share in 2022.

By application, the Middle East & Africa dPCR and qPCR market is segmented into research application, clinical application, and forensic application. The clinical application segment held the largest share in 2022. The clinical application segment is further subsegmented into oncology testing, blood screening, infectious disease testing, and other applications.

By end user, the Middle East & Africa dPCR and qPCR market is segmented into segmented into hospitals and diagnostic centers, pharmaceutical and biotechnology companies, research laboratories and academic institutes, forensic laboratories, and clinical research organizations. The hospitals and diagnostic centers segment held the largest share in 2022.

Based on country, the Middle East & Africa dPCR and qPCR market is segmented into segmented into Saudi Arabia, South Africa, the UAE, and the Rest of Middle East & Africa. Saudi Arabia dominated the Middle East & Africa dPCR and qPCR market in 2022.

Abbott Laboratories, Agilent Technologies Inc, Bio-Rad Laboratories Inc, F. Hoffmann-La Roche Ltd, Qiagen NV, Standard BioTools Inc, Takara Bio Inc, and Thermo Fisher Scientific Inc are some of the leading companies operating in the Middle East & Africa dPCR and qPCR market.

Product Code: BMIRE00029881

1. Introduction

1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. Middle East & Africa dPCR and qPCR Market Landscape

4.1 Overview
4.2 Middle East & Africa PEST Analysis

5. Middle East & Africa dPCR and qPCR Market - Key Industry Dynamics

5.1 Market Drivers
- 5.1.1 Increasing Incidence of Genetic and Infectious Diseases
- 5.1.2 Rising Investments and Funds for Gene Synthesis
- 5.1.3 Technological Advancements in PCR Technologies
5.2 Market Restraints
- 5.2.1 High Costs of PCR Systems
- 5.2.2 Technical Limitations Associated with qPCR
5.3 Market Opportunities
- 5.3.1 Growing Adoption of PCR Methods in Emerging Countries
5.4 Future Trends
- 5.4.1 Development of Droplet Digital PCR
5.5 Impact Analysis:

6. dPCR and qPCR Market - Middle East & Africa Market Analysis

6.1 Middle East & Africa dPCR and qPCR Market Revenue (US$ Mn), 2022 - 2030

7. Middle East & Africa dPCR and qPCR Market - Revenue and Forecast to 2030 - by Treatment

7.1 Overview
7.2 Middle East & Africa dPCR and qPCR Market Revenue Share, by Treatment, 2022 & 2030 (%)
7.3 Quantitative PCR
- 7.3.1 Overview
- 7.3.2 Quantitative PCR: Middle East & Africa dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
7.4 Digital PCR
- 7.4.1 Overview
- 7.4.2 Digital PCR: Middle East & Africa dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)

8. Middle East & Africa dPCR and qPCR Market - Revenue and Forecast to 2030 - by Product

8.1 Overview
8.2 Middle East & Africa dPCR and qPCR Market Revenue Share, by Product, 2022 & 2030 (%)
8.3 Reagents & Consumables
- 8.3.1 Overview
- 8.3.2 Reagents & Consumables: Middle East & Africa dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
8.4 Instruments
- 8.4.1 Overview
- 8.4.2 Instruments: Middle East & Africa dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
8.5 Software & Services
- 8.5.1 Overview
- 8.5.2 Software & Services: Middle East & Africa dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)

9. Middle East & Africa dPCR and qPCR Market - Revenue and Forecast to 2030 - by Application

9.1 Overview
9.2 Middle East & Africa dPCR and qPCR Market Revenue Share, by Application, 2022 & 2030 (%)
9.3 Research Application
- 9.3.1 Overview
- 9.3.2 Research Application: Middle East & Africa dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
9.4 Clinical Application
- 9.4.1 Overview
- 9.4.2 Clinical Application: Middle East & Africa dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
  - 9.4.2.1 Middle East & Africa dPCR and qPCR Market, by Clinical Application, 2020-2030 (US$ Million)
9.5 Forensic Application
- 9.5.1 Overview
- 9.5.2 Forensic Application: Middle East & Africa dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)

10. Middle East & Africa dPCR and qPCR Market - Revenue and Forecast to 2030 - by End-User

10.1 Overview
10.2 Middle East & Africa dPCR and qPCR Market Revenue Share, by End-User, 2022 & 2030 (%)
10.3 Hospitals and Diagnostic Centers
- 10.3.1 Overview
- 10.3.2 Hospitals and Diagnostic Centers: Middle East & Africa dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
10.4 Pharmaceutical and Biotechnology Companies
- 10.4.1 Overview
- 10.4.2 Pharmaceutical and Biotechnology Companies: Middle East & Africa dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
10.5 Research Laboratories and Academic Institutes
- 10.5.1 Overview
- 10.5.2 Research Laboratories and Academic Institutes: Middle East & Africa dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
10.6 Forensic Laboratories
- 10.6.1 Overview
- 10.6.2 Forensic Laboratories: Middle East & Africa dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
10.7 Clinical Research Organizations
- 10.7.1 Overview
- 10.7.2 Clinical Research Organizations: Middle East & Africa dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)

11. Middle East & Africa dPCR and qPCR Market - Country Analysis

11.1.1.1 Middle East & Africa dPCR and qPCR Market, by Country
11.1.1.2 Saudi Arabia
- 11.1.1.2.1 Saudi Arabia: Middle East & Africa dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
- 11.1.1.2.2 Saudi Arabia: Middle East & Africa dPCR and qPCR Market, by Treatment, 2020-2030 (US$ Million)
- 11.1.1.2.3 Saudi Arabia: Middle East & Africa dPCR and qPCR Market, by Product, 2020-2030 (US$ Million)
- 11.1.1.2.4 Saudi Arabia: Middle East & Africa dPCR and qPCR Market, by Application, 2020-2030 (US$ Million)
- 11.1.1.2.4.1 Saudi Arabia: Middle East & Africa dPCR and qPCR Market, for Clinical Application by Application, 2020 - 2030 (US$ Million)
- 11.1.1.2.5 Saudi Arabia: Middle East & Africa dPCR and qPCR Market, by End-User, 2020-2030 (US$ Million)
11.1.1.3 UAE
- 11.1.1.3.1 UAE Middle East & Africa dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
- 11.1.1.3.2 UAE: Middle East & Africa dPCR and qPCR Market, by Treatment, 2020-2030 (US$ Million)
- 11.1.1.3.3 UAE: Middle East & Africa dPCR and qPCR Market, by Product, 2020-2030 (US$ Million)
- 11.1.1.3.4 UAE: Middle East & Africa dPCR and qPCR Market, by Application, 2020-2030 (US$ Million)
- 11.1.1.3.4.1 UAE: Middle East & Africa dPCR and qPCR Market, for Clinical Application by Application, 2020 - 2030 (US$ Million)
- 11.1.1.3.5 UAE: Middle East & Africa dPCR and qPCR Market, by End-User, 2020-2030 (US$ Million)
11.1.1.4 South Africa
- 11.1.1.4.1 South Africa: Middle East & Africa dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
- 11.1.1.4.2 South Africa: Middle East & Africa dPCR and qPCR Market, by Treatment, 2020-2030 (US$ Million)
- 11.1.1.4.3 South Africa: Middle East & Africa dPCR and qPCR Market, by Product, 2020-2030 (US$ Million)
- 11.1.1.4.4 South Africa: Middle East & Africa dPCR and qPCR Market, by Application, 2020-2030 (US$ Million)
- 11.1.1.4.4.1 South Africa: Middle East & Africa dPCR and qPCR Market, for Clinical Application by Application, 2020 - 2030 (US$ Million)
- 11.1.1.4.5 South Africa: Middle East & Africa dPCR and qPCR Market, by End-User, 2020-2030 (US$ Million)
11.1.1.5 Rest of Middle East & Africa
- 11.1.1.5.1 Rest of Middle East & Africa: Middle East & Africa dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
- 11.1.1.5.2 Rest of Middle East & Africa: Middle East & Africa dPCR and qPCR Market, by Treatment, 2020-2030 (US$ Million)
- 11.1.1.5.3 Rest of Middle East & Africa: Middle East & Africa dPCR and qPCR Market, by Product, 2020-2030 (US$ Million)
- 11.1.1.5.4 Rest of Middle East & Africa: Middle East & Africa dPCR and qPCR Market, by Application, 2020-2030 (US$ Million)
- 11.1.1.5.4.1 Rest of Middle East & Africa: Middle East & Africa dPCR and qPCR Market, for Clinical Application by Application, 2020 - 2030 (US$ Million)
- 11.1.1.5.5 Rest of Middle East & Africa: Middle East & Africa dPCR and qPCR Market, by End-User, 2020-2030 (US$ Million)

12. dPCR and qPCR Market-Industry Landscape

12.1 Overview
12.2 Growth Strategies in Middle East & Africa dPCR and qPCR Market
12.3 Organic Growth Strategies
- 12.3.1 Overview
12.4 Inorganic Growth Strategies
- 12.4.1 Overview

13. Company Profiles

13.1 Abbott Laboratories
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
13.2 Thermo Fisher Scientific Inc
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
13.3 Takara Bio Inc
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
13.4 Qiagen NV
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments
13.5 Standard BioTools Inc
- 13.5.1 Key Facts
- 13.5.2 Business Description
- 13.5.3 Products and Services
- 13.5.4 Financial Overview
- 13.5.5 SWOT Analysis
- 13.5.6 Key Developments
13.6 F. Hoffmann-La Roche Ltd
- 13.6.1 Key Facts
- 13.6.2 Business Description
- 13.6.3 Products and Services
- 13.6.4 Financial Overview
- 13.6.5 SWOT Analysis
- 13.6.6 Key Developments
13.7 Bio-Rad Laboratories Inc
- 13.7.1 Key Facts
- 13.7.2 Business Description
- 13.7.3 Products and Services
- 13.7.4 Financial Overview
- 13.7.5 SWOT Analysis
- 13.7.6 Key Developments
13.8 Agilent Technologies Inc
- 13.8.1 Key Facts
- 13.8.2 Business Description
- 13.8.3 Products and Services
- 13.8.4 Financial Overview
- 13.8.5 SWOT Analysis
- 13.8.6 Key Developments

14. Appendix

14.1 About Us
14.2 Glossary of Terms